20 June 2013
Keywords: fda, oks, aventis, taxotere, prostate, cancer, food
Article | 24 May 2004
The US Food and Drug Administration has approved the use of Aventis' Taxotere (docetaxel) Injection Concentrate, in combination with
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 May 2004
10 May 2004
19 June 2013
© 2013 thepharmaletter.com